COVID-19 vaccine shortages hit poorer countries after India stops exporting jabs from Serum Institute

In the past two weeks, only 2 million doses were cleared for shipment to 92 countries through the COVAX programme, the same amount injected in Britain alone

The Associated Press April 11, 2021 08:41:21 IST

London: As many as 60 countries might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global programme are blocked until as late as June.

The COVAX initiative is designed to provide vaccines to countries lacking the clout to negotiate on their own for scarce supplies.

In the past two weeks, only 2 million doses were cleared for shipment to 92 countries through the program, the same amount injected in Britain alone.

Internal World Health Organization documents obtained by The Associated Press say uncertain deliveries are causing some countries to lose faith in COVAX.

The vaccine shortage stems mostly from India's decision to stop exporting vaccines from its Serum Institute factory because of a surge of coronavirus cases in that country. The factory produces the majority of the AstraZeneca doses that COVAX counted on to supply about a third of the global population.

WHO Director General Tedros Adhanom Ghebreysus says while one in four people in rich countries had received a vaccine, only one in 500 people in poorer countries had received a dose.

Updated Date: April 11, 2021 08:41:21 IST

also read


COVID-19 vaccine: Bharat Biotech cuts Covaxin price for states from Rs 600 to Rs 400 per dose

The price per dose for private buyers — which includes private hospitals — continues to be Rs 1,200, as the statement doesn't specify information about this


Joe Biden’s ‘America First’ policy on vaccines may create a serious wrinkle in bilateral ties as pandemic ravages India

When the US claims moral leadership and professes to be a normative superpower, then it must defer to its moral obligations or else risk the unraveling of its power


Centre asks Serum Institute and Bharat Biotech to lower prices of COVID-19 vaccines

The decision comes after many state governments have objected to different prices of the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this is not time for "profiteering"